MLchartDataset catalogue

eplerenone

Term · Oncology and biomedicine · MLC-T-ONC-013390

A selective aldosterone receptor antagonist. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, thereby decreasing sodium resorption and subsequently increasing water outflow. This leads to a decrease in blood pressure. Eplerenone is used in the treatment of hypertension and congestive heart failure.

Table 1. Record
IdentifierMLC-T-ONC-013390
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013390",
  "term": "eplerenone",
  "field": "Oncology and biomedicine",
  "definition": "A selective aldosterone receptor antagonist. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, thereby decreasing sodium resorption and subsequently increasing water outflow. This leads to a decrease in blood pressure. Eplerenone is used in the treatment of hypertension and congestive heart failure.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/eplerenone/"
}

Record 6,798 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.